
|Videos|November 30, 2022
The Importance of Molecular Testing in Metastatic Colorectal Cancer
Dr Tanios Bekaii-Saab explains the rarity of HER2+ metastatic colorectal cancer and how his clinical practice detects HER2 alterations.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
One of “The Best Opportunities” for Long-Term Remission in Multiple Myeloma
2
Blood-Based Lung Cancer Screening Tool Earns FDA Breakthrough Device Status
3
What Does Priority Review Mean for Subcutaneous Amivantamab in HNSCC?
4
What Are The Biggest Misconceptions About CAR T Cells in Multiple Myeloma?
5























































